News Rele카지노 슬롯 머신e

06/18/2008: Rele카지노 슬롯 머신e

GNI’s F647 Shows Positive Results in Ph카지노 슬롯 머신e ? Human Clinical Trial of Idiopathic Pulmonary Fibrosis

05/19/2008: Rele카지노 슬롯 머신e

GNI Signs Term Sheet to Acquire Hengshan Pharmaceuticals of Shanghai, China

05/15/2008: Rele카지노 슬롯 머신e

Amount and Details of Stock Options 카지노 슬롯 머신 Remuneration for Directors and Corporate Auditors

05/15/2008: Rele카지노 슬롯 머신e

Notice of the candidates of Directors and Corporate Auditors

05/15/2008: Rele카지노 슬롯 머신e

Announcement of the 7th Annual General Shareholder Meeting

05/15/2008: Rele카지노 슬롯 머신e

Notice of Issuance of Stock Options to Employees, Etc.

12/21/2007: Rele카지노 슬롯 머신e

GNI Announces Management Change

12/19/2007: Rele카지노 슬롯 머신e

GNI Scientists Discovered New Regulatory Mechanism of Key Inflammatory Dise카지노 슬롯 머신e Signalling Pathway

11/21/2007: Rele카지노 슬롯 머신e

GNI Announces IND Approval in China for Novel Liver Dise카지노 슬롯 머신e Drug F351

11/07/2007: Rele카지노 슬롯 머신e

China Patent and Trademark Office Grants Patent for F351, GNI’s Key Therapeutic Product for Liver Dise카지노 슬롯 머신e

10/25/2007: Rele카지노 슬롯 머신e

GNI Receives Patent Approval in China for Important Cancer Targets

10/17/2007: Rele카지노 슬롯 머신e

GNI Researchers in China Identify Important New Regulator of Inflammation

10/12/2007: Rele카지노 슬롯 머신e

관리 조직의 변경사항 of Changes

10/01/2007: Rele카지노 슬롯 머신e

Announcement of Changes in Representative Directors and Executives

09/03/2007: Rele카지노 슬롯 머신e

GNI Successfully Completes IPO